Gene Therapy and Pharmacogenomics
TerGenOMIC
![Foto de Gene Therapy and Pharmacogenomics](/img/grupo.png)
![Foto de Universidad de La Frontera](/img/noimage_org.png)
Universidad de La Frontera
Temuco, ChilePublications in collaboration with researchers from Universidad de La Frontera (1)
2019
-
CYP3A5∗3 and CYP2C8∗3 variants influence exposure and clinical outcomes of tacrolimus-based therapy
Pharmacogenomics, Vol. 21, Núm. 1, pp. 7-21